Nasdaq · Financials
GoHealth, Inc. (GOCOQ)
As-reported financials and recent SEC filings for GoHealth, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$361.8M
Net income
$-257.1M
Net margin
-71.1%
Diluted EPS
$-20.17
ROE
413.4%
P/E (TTM)
—
Market cap
$10.7M
Debt / equity
-10.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $361.8M | $798.9M | $734.7M | $631.7M | $1.06B |
| Gross profit | $265.7M | $668.3M | $575.7M | $444.0M | $823.1M |
| Operating income | $-412.9M | $-7.0M | $-81.7M | $-318.7M | $-489.4M |
| Net income | $-257.1M | $-2.9M | $-63.3M | $-148.7M | $-189.4M |
| Diluted EPS | $-20.17 | $-0.66 | $-7.19 | $-17.72 | $-26.80 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-11
View on EDGAR →8-K2026-06-08
View on EDGAR →10-Q2026-05-18
View on EDGAR →NT 10-Q2026-05-18
View on EDGAR →DEFA14A2026-04-30
View on EDGAR →DEF 14A2026-04-30
View on EDGAR →10-K2026-03-31
View on EDGAR →8-K2026-03-31
View on EDGAR →Go deeper on GOCOQ
Search GoHealth, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.